Institutional Ownership
Cellect Biotechnology Ltd
CUSIP 15116C201COMMON STOCK-FOQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Feb 16, 2021
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 16, 2021 | Cvi Investments, Inc. | 13G/A | — | — | SEC |
| 2 | Jan 13, 2021 | Empery Asset Management, LP | 13G | 0.1% | 1.9K | SEC |
| 3 | Jan 17, 2020 | Cvi Investments, Inc. | 13G | 9.4% | 30.50M | SEC |
| 4 | Jan 10, 2020 | Empery Asset Management, LP | 13G | 10.0% | 323.0K | SEC |
| 5 | Jan 3, 2020 | Sabby Management, LLC | 13G/A | — | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $6 |